MicroRNAs involvement in the inhibition of the TGF-β/SMAD cascade was extensively reported in mice models with MI, and cardiac hypertrophy41,42 and addressed as a therapeutic strategy for patients with HF.43 The gene discussed is TGFB1; the disease is myocardial infarction.